France / Français
Enrollment complete in Graybug's phase 2b wet AMD treatment trial
The final patient has been enrolled in a phase 2b trial of Graybug Vision's wet age-related macular degeneration treatment candidate, according to a press release. The...
17 days ago - Healio
Visual acuity, injection frequency decrease over time in real-world AMD study
In a retrospective study, patients with neovascular age-related macular degeneration treated with anti-VEGF injections experienced decreased visual acuity from baseline and...
18 days ago - Healio
Tooth-enamel protein discovered in the eyes of people with dry AMD
A protein that normally deposits mineralized calcium in tooth enamel may also be responsible for calcium deposits in the back of the eye in people with dry age-related macular...
22 days ago - News Medical
Final visual outcomes worse after anti-VEGF treatment lapse
PHILADELPHIA - Patients with neovascular age-related macular degeneration receiving intravitreal anti-VEGF injections should be encouraged to adhere to their treatment regimen...
26 days ago - Healio
Santen, Tracon discontinue development of wet AMD treatment
Santen and Tracon Pharmaceuticals have discontinued development of DE-122, their wet age-related macular degeneration treatment candidate, following data analysis of a phase 2a...
26 days ago - Healio
VIDEO: AI leads patients through head-mounted AMD test
ATLANTA - Maculogix has taken the 45-pound tabletop dark adaptation testing device, AdaptDx, and turned it into a head-mounted technology managed by an onboard artificial...
1 month ago - Healio
Scientists make important discovery with implications for people living with AMD
Scientists from Trinity College Dublin have made an important discovery with implications for those living with a common, debilitating eye disease that can cause blindness.
1 month ago - News Medical - 2 articles
Repeated injections for AMD increase glaucoma risk
Researchers in Wheaton, Ill., reported that patients with age-related macular degeneration were more likely to develop glaucoma and its risk factor, ocular hypertension, when...
1 month ago - Healio
Beovu approved for wet AMD in Europe
The European Commission has approved Beovu for the treatment of wet age-related macular degeneration, Novartis announced in a press release. Beovu is the first anti-VEGF...
1 month ago - Healio
Periodontal disease may be risk factor for AMD
Periodontal diseases are a possible additional risk factor for age-related macular degeneration; however, the link between the two remains unclear, according to a literature...
1 month ago - Healio - 2 articles
Free Registration
The headlines of Master Doctor
My Stepfather Is Fighting For His Life With COVID-19
My mother met James Lee at Lenox House Senior Center. She was 68, he was a mere 67. My mom was long divorced , going broke, living in the East Side rent-controlled apartment in...
Coronavirus Live Updates: Boris Johnson Moved to I.C.U. After Symptoms Worsen
A senior White House official warned President Trump in January that a pandemic would cost millions of lives and trillions of dollars. Mr. Johnson, Britain's prime minister...
Alzheimer's trial screening data links high amyloid levels with early stage...
A new study supports the hypothesis that higher levels of amyloid protein in the brain represent an early stage of Alzheimer's disease. Screening data for the study show that...
Senior Living: Go cashless at your own pace
We are on continuing trend toward online services and a cashless society. While we know there is a growing movement to drive our financial system to a greater digital platform...
Nursing Home Advocates Call For More Funds, Tests, and PPE As Concerns Over...
"We do expect that more residents will test positive," said the head of the Massachusetts Senior Care Association.
VIDEO: Pearls for canal-based microstents in cataract surgery
KOLOA, Hawaii - At Hawaiian Eye 2020, Savak “Sev” Teymoorian, MD, MBA, of Harvard Eye Associates in Laguna Hills, California, discusses best current practices for the use of...